X hits on this document

19 views

0 shares

0 downloads

0 comments

8 / 9

Medications for the Treatment of Paget’s Disease

Coverage of Alendronate, Risedronate, and Zoledronic Acid for the treatment of Paget’s Disease have been approved for patients who meet established clinical criteria and who are eligible for coverage through the Family Health Benefit, Financial Assistance, Seniors, and Nursing Home Programs. A completed Special Authorization form must be received by the Drug Programs office before coverage will be considered. Patients will be required to pay the normal prescription

copays for these programs.

02201038

FOSAMAX

02258102

CO-ALENDRONATE

ALENDRONATE 40MG TABLET

MSD COB

For the treatment of Paget’s disease of bone for a maximum 6 month period. A copy of the radiological or specialist report supporting the diagnosis must accompany the Special Authorization.

RISEDRONATE

30MG TABLET 02239146

ACTONEL

PGA

For the treatment of Paget’s disease of bone for a maximum 2 month period. One additional 2 month course of treatment may be considered after a drug holiday of at least 60 days. A copy of the radiological or specialist report supporting the diagnosis must accompany the Special Authorization.

ZOLEDRONIC ACID

5MG/100ML INJECTION SOLUTION (VIAL)

02269198

ACLASTA

NVR

For the treatment of Paget’s disease of the bone. A copy of the radiological or specialist report supporting the diagnosis must accompany the Special Authorization.

HIV/AIDS Medications

The following medications have been approved for the coverage through the HIV/AIDS Program. All prescriptions for the

HIV/AIDS Program must be filled at the Provincial Pharmacy located in Charlottetown.

DRONABINOL 2.5MG CAPSULE 00611190

MARINOL

SLV

5MG CAPSULE 00611204

MARINOL

SLV

For the treatment of acquired immune deficiency syndrome (AIDS)-related anorexia associated with weight loss.

EFAVIRENZ & EMBRICITABINE & TENOFOVIR

600MG & 200MG & 300MG TABLET

02300699

ATRIPLA

PFI

ETRAVIRINE 100MG TABLET 02306778

INTELENCE

JAN

PEI Drug Programs Update - Issue 09-01- Page 8

Document info
Document views19
Page views19
Page last viewedWed Dec 07 12:46:00 UTC 2016
Pages9
Paragraphs383
Words2500

Comments